Page 3 - Best Arteriovenous malformation doctors: TOP 45 doctors

Led Bangkok Hospital Chanthaburi's first endoscopic transsphenoidal surgery – a minimally invasive brain procedure that reduces recovery time and risks.

• 15+ years of experience in neurosurgery and regenerative medicine
• Trained at Siriraj Hospital and International Neuroscience Institute in Germany
• Chief Physician at EDNA Wellness, leading Stem Cell Therapy and Neurology Department
• Authored research papers on cerebrovascular disorders and spine conditions

Specializes in complex brain and spine surgeries, including AVM and aneurysm procedures at Liv Hospital Vadistanbul.

• Performs aneurysm, AVM, and cavernoma surgeries
• Skilled in pediatric neurosurgery for congenital conditions
• Expert in deep brain stimulation for movement disorders
• Board-certified neurosurgeon with over 10 years of experience

Specializes in functional neurosurgery for arteriovenous malformations – Dr. Cal combines clinical expertise with research at Liv Hospital Ulus.

• Expertise in neuro-oncological and pediatric neurosurgery
• Published multiple studies on brain tumors and neurosurgical techniques
• Member of the Turkish Neurosurgery Association

Dr. Halil Can is a Professor of Neurosurgery (2025; Associate Professor 2020). He completed neurosurgical training at Istanbul University–Istanbul Faculty of Medicine in 2007. His clinical focus includes endoscopic and microsurgical spine surgery for fractures, tumors, and degenerative disease; advanced pain procedures; endoscopic skull base and pituitary surgery; and neurovascular, neuro-oncologic, and peripheral nerve surgery.

He has 21 international peer-reviewed papers (SCI/SSCI). Topics include cadaveric morphometry of Kambin’s triangle and the transforaminal triangular working zone, lumbar arterial and anterior approach anatomy, and an in vitro test of a new lumbar fixation device.

His clinical studies include a single-team series of 81 posterior circulation aneurysms, with 13 flow-diversion cases. He also reported five spinal cavernous malformation cases. He conducted Phase I safety and feasibility stem-cell trials in pediatric hypoxic-ischemic encephalopathy and in chronic complete spinal cord injury.